Academic Journal
View in EDS

Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel

Bibliographic Details
Title: Bone Biomarkers and Subsequent Survival in Men with Hormone-sensitive Prostate Cancer: Results from the SWOG S1216 Phase 3 Trial of Androgen Deprivation Therapy with or Without Orteronel
Authors: Lara Jr, Primo N., Mayerson, Edward, Gertz, Erik, Tangen, Catherine, Goldkorn, Amir, van Loan, Marta, Hussain, Maha, Gupta, Shilpa, Zhang, Jingsong, Parikh, Mamta, Twardowski, Przemyslaw, Quinn, David I., LeBlanc, Michael, Vogelzang, Nicholas J., Thompson, Ian, Agarwal, Neeraj
Source: In European Urology February 2024 85(2):171-176
Database: ScienceDirect
More Details
ISSN:03022838
DOI:10.1016/j.eururo.2023.03.036
Published in:European Urology
Language:English